Breaking News on Drug Quality: CDSCO's Warning on Substandard High Blood Pressure Medications
Major Alert: Substandard Drugs in India
In a shocking report, the Central Drug Standards Control Organisation (CDSCO) has revealed that over 50 commonly used drugs in India are found to be substandard. These include medications prescribed for high blood pressure and other ailments. The findings have put immense pressure on pharmaceutical companies involved.
Details of the Findings
- A specific batch of Pulmosil (Sildenafil injection), manufactured by Sun Pharmaceuticals, was flagged as not-of-standard quality.
- Similarly, another batch of Pantocid, used for acid reflux, was also declared spurious.
- Furthermore, Glenmark Pharmaceuticals was implicated when one batch of Telma H failed to meet quality standards.
- Additionally, Alkem Health Science's product, Clavam 625, was found below acceptable quality levels.
This situation calls for immediate attention to drug safety and the regulations that govern the pharmaceutical industry in India. The CDSCO is urging consumers to be cautious and informed about medications they purchase.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.